AdvisorShares Investments LLC launched its first exchange-traded fund today: the actively managed AdvisorShares Dent Tactical ETF.
Bill Gross, managing director and co-chief investment officer at Pacific Investment Management Co., will deliver the keynote address at InvestmentNews' ETF Insights online conference for financial advisers, which will explore the latest developments in exchange-traded funds.
When it comes to leveraged and inverse ETFs, seemingly every regulator and influential brokerage firm has recently voiced the opinion that these exotic vehicles - which can double or triple the returns (or short the losses) of a market index - are inappropriate for individual investors.
Exchange-traded funds are poised to take a bite out of traditional mutual funds and are expected to grow from just over half a trillion dollars to $1 trillion before 2011, according to a soon-to-be-released report.
Two major financial services firms — an investment banking company and a an insurer — have revealed their intentions to get into the exchange-traded fund business.
Regulators are imposing new restrictions on leveraged exchange-traded funds, volatile investments that can multiply the gains or losses of a market index or benchmark.
It is not the first exchange traded fund to invest in Treasury Inflation-Protected Securities, but the TIPS ETF launched today by Pacific Investment Management Co. of Newport Beach, Calif., may quickly become the fan favorite, according to a Morningstar anaylst.
The Securities and Exchange Commission and the Commodity Futures Trading Commission inserted themselves into the debate surrounding controversial, non-traditional exchange traded funds last week — a debate that could harm the entire ETF sector, according to some industry insiders.
Even as ETFs continue to take market share away from mutual funds and gain more popularity with retail investors and advisers, officials for Fidelity Investments are maintaining that the fund giant is unlikely to expand its proprietary exchange traded fund lineup.
ProShares Advisors LLC announced today the launch of a third exchange traded fund that lets investors bet on a downturn in long-term U.S. Treasury bonds.
Two law firms are investigating potential claims on behalf of retail investors who purchased leveraged, inverse and leveraged-inverse exchange traded funds and held them in their brokerage accounts for longer than one day.
The Securities and Exchange Commission today got behind the Financial Industry Regulatory Authority Inc.'s effort to alert investors about the potential pitfalls of leveraged, inverse and leveraged-inverse exchange traded funds.
The Vanguard Group Inc. last week filed a registration statement with the Securities and Exchange Commission to offer seven bond index exchange traded funds in what some industry experts think will be a direct challenge to iShares, the dominant fixed-income ETF provider.
Vanguard today filed a registration statement with the Securities and Exchange Commission to offer seven new bond index exchange traded funds in what some industry experts believe to be a direct challenge to iShares, the dominant fixed-income ETF provider.
Massachusetts regulators sent subpoenas to four brokerage firms July 31 seeking information about the way they sold inverse and leveraged exchange traded funds. The subpoenas were issued weeks after the firms restricted the sale of the products or stopped selling them altogether.
Exchange traded fund assets worldwide hit an all-time high of $862 billion at the end of July, 7% above the previous record of $805 billion set in April 2008, according to data released today from the London-based research team of Barclays Global Investors in San Francisco.
Morgan Stanley Smith Barney LLC today announced restrictions on the sale of leveraged, inverse, and leveraged-inverse exchange traded funds by its brokers and advisers.
Massachusetts regulators sent subpoenas to four brokerage firms on Friday asking about their sales practices relating to inverse and leveraged exchange traded funds weeks after Edward D. Jones, Ameriprise, LPL and UBS restricting the sale of the products or stopped selling them altogether.
